Ipsen seeks an experienced Early Development Asset Lead to manage integrated strategies for one or more early-stage assets from nomination through first-in-human trials. You will lead the EDT, coordinating clinical, regulatory, translational, and nonclinical teams to advance programs with scientific rigor and portfolio alignment.
The role requires a PhD/MD/PharmD or equivalent with 10–15 years in multidisciplinary drug development, and strong leadership in a global, matrix organization.
#J-18808-Ljbffr
Early Development Asset Lead - Shape Translational Strategy employer: Ipsen
Ipsen Biopharm Ltd is an exceptional employer that prioritises a human-centric workplace culture, fostering collaboration and excellence. With a commitment to employee growth, Ipsen offers opportunities for continuous improvement and innovation in the biopharmaceutical field, particularly in vibrant locations like Paris and London. Employees are empowered to thrive, making a meaningful impact on patients and society while enjoying a supportive environment that values diverse perspectives.
